CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort-Reference-Cited by-同舟云学术

CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort

Published:2022-06-15 Issue:12 Volume:205 Page:1440-1448
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Molyneaux Philip L.¹²,Fahy William A.³,Byrne Adam J.¹,Braybrooke Rebecca⁴,Saunders Peter¹,Toshner Richard¹,Albers Gesa¹,Chua Felix¹²,Renzoni Elisabetta A.¹²,Wells Athol U.¹²,Karkera Yakshitha⁵,Oballa Eunice³,Saini Gauri⁴^ORCID,Nicholson Andrew G.¹²,Jenkins R. Gisli¹,Maher Toby M.¹²⁶⁷^ORCID

Affiliation:

1. National Heart and Lung Institute, Imperial College London, London, United Kingdom;

2. Royal Brompton and Harefield Clinical Group, Guy’s and St. Thomas’ NHS Foundation Trust, London, United Kingdom;

3. Discovery Medicine, GlaxoSmithKline, Stevenage, United Kingdom;

4. Division of Respiratory Medicine, University of Nottingham, Nottingham, United Kingdom;

5. Biostatistics, GlaxoSmithKline R&D, Bangalore, India; and

6. Hastings Centre for Pulmonary Research and

7. Division of Pulmonary, Critical Care, and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California

Funder

GlaxoSmithKline

National Institute for Health Research

British Lung Foundation